Means Investment Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.6M | Sell |
27,981
-43
| -0.2% | -$5.03K | 0.27% | 46 |
|
|
2026
Q1 | $3.37M | Sell |
28,024
-1,000
| -3% | -$115K | 0.29% | 44 |
|
|
2025
Q4 | $3.06M | Sell |
29,024
-199
| -0.7% | -$18.7K | 0.26% | 47 |
|
|
2025
Q3 | $2.45M | Sell |
29,223
-173
| -0.6% | -$14.2K | 0.21% | 55 |
|
|
2025
Q2 | $2.33M | Buy |
29,396
+21
| +0.1% | +$1.67K | 0.22% | 53 |
|
|
2025
Q1 | $2.64M | Sell |
29,375
-1,270
| -4% | -$119K | 0.28% | 52 |
|
|
2024
Q4 | $3.05M | Sell |
30,645
-32
| -0.1% | -$3.3K | 0.32% | 50 |
|
|
2024
Q3 | $3.48M | Sell |
30,677
-175
| -0.6% | -$20.8K | 0.39% | 46 |
|
|
2024
Q2 | $3.82M | Sell |
30,852
-435
| -1% | -$56K | 0.46% | 38 |
|
|
2024
Q1 | $4.13M | Sell |
31,287
-477
| -2% | -$58.8K | 0.53% | 35 |
|
|
2023
Q4 | $3.46M | Sell |
31,764
-252
| -0.8% | -$26.2K | 0.5% | 41 |
|
|
2023
Q3 | $3.3M | Sell |
32,016
-868
| -3% | -$93.6K | 0.54% | 40 |
|
|
2023
Q2 | $3.79M | Sell |
32,884
-251
| -0.8% | -$28.5K | 0.6% | 37 |
|
|
2023
Q1 | $3.53M | Sell |
33,135
-315
| -0.9% | -$34K | 0.62% | 37 |
|
|
2022
Q4 | $3.71M | Sell |
33,450
-22
| -0.1% | -$2.25K | 0.74% | 32 |
|
|
2022
Q3 | $2.88M | Sell |
33,472
-168
| -0.5% | -$15K | 0.63% | 36 |
|
|
2022
Q2 | $3.07M | Sell |
33,640
-121
| -0.4% | -$10.7K | 0.65% | 34 |
|
|
2022
Q1 | $2.77M | Sell |
33,761
-156
| -0.5% | -$12.3K | 0.5% | 40 |
|
|
2021
Q4 | $2.6M | Sell |
33,917
-1,760
| -5% | -$140K | 0.46% | 43 |
|
|
2021
Q3 | $2.68M | Sell |
35,677
-1,026
| -3% | -$78K | 0.53% | 45 |
|
|
2021
Q2 | $2.85M | Sell |
36,703
-1,710
| -4% | -$127K | 0.57% | 36 |
|
|
2021
Q1 | $2.83M | Buy |
38,413
+113
| +0.3% | +$8.34K | 0.64% | 35 |
|
|
2020
Q4 | $2.73M | Buy |
38,300
+16
| +0% | +$1.22K | 0.62% | 35 |
|
|
2020
Q3 | $2.94M | Buy |
38,284
+88
| +0.2% | +$6.89K | 0.81% | 27 |
|
|
2020
Q2 | $2.95M | Buy |
38,196
+633
| +2% | +$47.7K | 0.92% | 25 |
|
|
2020
Q1 | $2.87M | Buy |
37,563
+232
| +0.6% | +$18.2K | 1.11% | 23 |
|
|
2019
Q4 | $3.24M | Buy |
37,331
+4,922
| +15% | +$404K | 1.09% | 22 |
|
|
2019
Q3 | $2.6M | Buy |
32,409
+160
| +0.5% | +$12.8K | 0.98% | 28 |
|
|
2019
Q2 | $2.61M | Sell |
32,249
-258
| -0.8% | -$19.8K | 1.07% | 24 |
|
|
2019
Q1 | $2.58M | Buy |
32,507
+10,995
| +51% | +$822K | 1.13% | 25 |
|
|
2018
Q4 | $1.57M | Buy |
+21,512
| New | +$1.52M | 0.87% | 33 |
|
Other funds holding MRK
Means Investment Company's MRK Position: Q2 2026 in Review
Means Investment Company reduced its Merck (MRK) stake by 0.15% in Q2 2026, selling an estimated $5.03K and leaving 27,981 shares worth $3.6M. The position accounts for 0.27% of the portfolio, ranked #46.
Means Investment Company first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.13M in Q1 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Means Investment Company held 27,981 shares of Merck worth $3.6M as of Q2 2026.
- Means Investment Company sold 43 Merck shares in Q2 2026, an estimated $5.03K.
- Merck made up 0.27% of Means Investment Company's portfolio in Q2 2026, its #46 holding.
- Means Investment Company first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Means Investment Company's Merck position peaked at $4.13M in Q1 2024.
- 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Means Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.